These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 2587620

  • 1. Effect of repeated administration of U-50,488H, a kappa opioid receptor agonist, on central 5-HT1 and 5-HT2 receptors in the rat.
    Gulati A, Ramarao P, Bhargava HN.
    Pharmacology; 1989; 39(3):145-53. PubMed ID: 2587620
    [Abstract] [Full Text] [Related]

  • 2. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.
    Bhargava HN, Gulati A, Ramarao P.
    J Pharmacol Exp Ther; 1989 Oct; 251(1):21-6. PubMed ID: 2552075
    [Abstract] [Full Text] [Related]

  • 3. Effect of chronic administration of U-50,488H, a kappa-opioid receptor agonist, on central dopamine D2 receptors of the rat.
    Veeranna, Reddy PL, Bhargava HN.
    Eur J Pharmacol; 1993 Apr 22; 235(1):23-30. PubMed ID: 8390939
    [Abstract] [Full Text] [Related]

  • 4. Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H.
    Ho BY, Takemori AE.
    J Pharmacol Exp Ther; 1989 Aug 22; 250(2):508-14. PubMed ID: 2547935
    [Abstract] [Full Text] [Related]

  • 5. Abstinence from U-50,488H, a kappa-opiate receptor agonist, decreases the binding of [3H]DPAT to 5-HT1A receptors in the hypothalamus of the rat.
    Reddy VP, Bhargava HN.
    Neuropharmacology; 1992 Dec 22; 31(12):1243-9. PubMed ID: 1470300
    [Abstract] [Full Text] [Related]

  • 6. Effects of acute and chronic administration of dizocilpine on the pharmacological responses to U-50,488H and brain and spinal cord kappa-opioid receptors in the rat.
    Bhargava HN, Matwyshyn GA, Gudehithlu KP.
    Pharmacology; 1995 Nov 22; 51(5):323-30. PubMed ID: 8584584
    [Abstract] [Full Text] [Related]

  • 7. Down-regulation of central receptors for thyrotropin-releasing hormone in kappa opiate agonist-induced abstinence in the rat.
    Bhargava HN, Gulati A, Rahmani NH.
    Neuropharmacology; 1992 Feb 22; 31(2):137-41. PubMed ID: 1313157
    [Abstract] [Full Text] [Related]

  • 8. Binding characteristics of [3H]SCH 23390 in spinal cord and discrete brain regions of kappa-opiate tolerant-dependent and abstinent rats.
    Bhargava HN, Gulati A, Ramarao P.
    Pharmacology; 1991 Feb 22; 42(3):121-7. PubMed ID: 1647533
    [Abstract] [Full Text] [Related]

  • 9. Effects of morphine in rats treated chronically with U-50,488 H, a kappa opioid receptor agonist.
    Bhargava HN, Ramarao P, Gulati A.
    Eur J Pharmacol; 1989 Mar 21; 162(2):257-64. PubMed ID: 2542058
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes.
    Rahmani NH, Gulati A, Bhargava HN.
    Pharmacology; 1991 Mar 21; 43(3):156-62. PubMed ID: 1663623
    [Abstract] [Full Text] [Related]

  • 11. Down-regulation of brain and spinal cord K-opiate receptors in spontaneously hypertensive, Wistar-Kyoto normotensive, and Sprague-Dawley rats by chronic treatment with U-50, 488H.
    Bhargava HN, Gulati A, Ramarao P.
    Biochem Pharmacol; 1991 Jun 21; 42(1):25-9. PubMed ID: 1648922
    [Abstract] [Full Text] [Related]

  • 12. Effect of repeated administration of U-50,488H on the binding of 3H-SCH 23390 and 3H-spiperone to rat brain and spinal cord dopamine receptors.
    Bhargava HN, Ramarao P, Gulati A.
    Prog Clin Biol Res; 1990 Jun 21; 328():153-6. PubMed ID: 2406759
    [No Abstract] [Full Text] [Related]

  • 13. beta-Endorphin-like immunoreactivity in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of U-50,488H-tolerant and -abstinent rats.
    Bhargava HN, Matwyshyn GA, Rattan AK, Koo KL, Tejwani GA.
    J Pharmacol Exp Ther; 1994 Feb 21; 268(2):856-61. PubMed ID: 8113998
    [Abstract] [Full Text] [Related]

  • 14. Brain and spinal cord kappa opiate receptors and pharmacological responses to U-50,488H in rats of differing ages.
    Bhargava HN, Matwyshyn GA, Reddy PL, Veeranna.
    Pharmacol Biochem Behav; 1994 May 21; 48(1):87-91. PubMed ID: 8029307
    [Abstract] [Full Text] [Related]

  • 15. Modification of the binding of [3H]MK-801 to brain regions and spinal cord of rats treated chronically with U-50,488H, a kappa-opioid receptor agonist.
    Bhargava HN, Kumar S.
    Brain Res; 1997 Feb 28; 749(2):347-50. PubMed ID: 9138737
    [Abstract] [Full Text] [Related]

  • 16. Biochemical and behavioral studies on the interaction between mu- and kappa-opiate agonists in mice.
    Thorat SN, Veeranna, Reddy PL, Bhargava HN.
    Brain Res; 1993 Jul 02; 615(2):191-8. PubMed ID: 8395957
    [Abstract] [Full Text] [Related]

  • 17. Antagonism of kappa opioid mediated effects in the rat by cyclo(Leu-Gly).
    Bhargava HN, Ramarao P.
    Life Sci; 1989 Jul 02; 45(26):2521-8. PubMed ID: 2559273
    [Abstract] [Full Text] [Related]

  • 18. Non-competitive antagonism of N-methyl-D-aspartate receptor inhibits tolerance to the analgesic action of U-50,488H, a kappa-opiate receptor agonist in the rat.
    Bhargava HN.
    Gen Pharmacol; 1995 Sep 02; 26(5):1055-60. PubMed ID: 7557250
    [Abstract] [Full Text] [Related]

  • 19. The effect of U-50,488H, a kappa-opiate receptor agonist on tolerance to the analgesic and hyperthermic effects of morphine in the rat.
    Bhargava HN, Matwyshyn G, Ramarao P.
    Gen Pharmacol; 1991 Sep 02; 22(3):429-34. PubMed ID: 1651266
    [Abstract] [Full Text] [Related]

  • 20. Release by U-50,488H of [3H]serotonin from brain slices and spinal cord synaptosomes of U-50,488H-tolerant and nontolerant mice.
    Ho BY, Takemori AE.
    J Pharmacol Exp Ther; 1990 Jul 02; 254(1):8-12. PubMed ID: 2164102
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.